Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects

Status:
Completed

Trial end date:
2018-10-13

Target enrollment:

Participant gender:

A Phase 1, Open-label Study of the absorption, metabolism, and excretion of a single oral dose of [14C]EDP-305 in healthy male subjects.

Phase 1

Enanta Pharmaceuticals